MR correlates of cerebral atrophy in patients with multiple sclerosis

Journal of Neurology

Volumn 249, Issue 8, 2002, Pages 1072-1077

  De Stefano, Nicola ^a   Iannucci, Giuseppe ^b   Sormani, Maria P ^b   Guidi, Leonello ^c   Bartolozzi, Maria L ^c   Comi, Giancarlo ^b   Federico, Antonio ^a   Filippi, Massimo ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b Scientific Institute   (Italy)

^c Hospital of Empoli   (Italy)

Author keywords

Axonal damage; Brain atrophy; Diffusion; Magnetic resonance spectroscopy; Multiple sclerosis

Indexed keywords

CREATINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN INJURY; BRAIN SIZE; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION; DIFFUSION TENSOR IMAGING; DISEASE COURSE; DISEASE MARKER; HUMAN; IN VIVO STUDY; MULTIPLE SCLEROSIS; NERVE FIBER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RELAPSE; REMISSION; SCORING SYSTEM;

ADULT; ATROPHY; BRAIN; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING;

EID: 0036038502     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-002-0790-5     Document Type: Article

References (43)

1. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease
2. 1H NMR spectroscopy in Canavan's disease: A report of two cases
3. Estimation of the effective self-diffusion tensor from the NMR spin echo
4. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI
5. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients
6. Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis
7. Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI
8. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions
9. Application of time-domain fitting in the quantification of in vivo 1H spectroscopic imaging data sets
10. Chemical pathology of acute demyelinating lesions and its correlation with disability
11. Reversible decreases in N-acetylaspartate after acute brain injury
12. Axonal damage in acute multiple sclerosis lesions
13. Linking structural, metabolic and functional changes in multiple sclerosis
14. Diffusion tensor magnetic resonance imaging in multiple sclerosis
15. Normal-appearing white matter changes in multiple sclerosis: The contribution of magnetic resonance techniques
16. Imaging of onset and progression of Alzheimer's disease with voxel- compression mapping of serial magnetic resonance images
17. Progressive cerebral atrophy in MS: A serial study using registered, volumetric MRI
18. Total brain N-acetylaspartate: A new measure of disease load in MS
19. Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging
20. Cortical lesions in multiple sclerosis
21. Neurologic impairment in multiple sclerosis and the disability status scale
22. Imaging of diffusion and microcirculation with gradient sensitization: Design, strategy, and significance
23. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study
24. Defining the clinical course of multiple sclerosis: Results of an international survey
25. Correlates of MS disability assessed in vivo using aggregates of MR quantities
26. Absence of N-acetylaspartate in the human brain: Impact on neurospectroscopy?
27. Putting magnetic resonance spectroscopy studies in context: Axonal damage and disability in multiple sclerosis
28. Course and prognosis
29. Immunohistochemical localization of N-acetylas-partate in rat brain
30. Measurement of regional N-acetylaspartate after transient global ischemia in gerbils with and without ischemic tolerance: An index of neuronal survival
31. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis
32. Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia
33. 2-weighted images
34. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS Multiple Sclerosis Collaborative Research Group
35. Axonal degeneration in the pathogenesis of multiple sclerosis
36. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies
37. A longitudinal study of brain atrophy in relapsing multiple sclerosis
38. Normalized accurate measurement of longitudinal brain change
39. Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures
40. Axonal transection in the lesions of multiple sclerosis
41. Neurodegeneration in multiple sclerosis: Relationship to neurological disability
42. Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy
43. Segmentation of brain MR images through a hidden Markov random field model and the expectation maximization algorithm